| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 18, 2026 | Sigma-Aldrich Adds Electroninks’ 'UT Dots' Advanced Gold and Silver Nanoparticle Inks to Product Offering | UT Dots expands global availability of conductive ink formulations of high conductivity and precision deposition for next-gen electronic and medical devices AUSTIN, TX, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Electroninks, the lea... |
| May 10, 2026 | Прочитал свой геном на кухне и превратил мазок щеки в 30 гигабаз данных ДНК | Перед вами перевод статьи о том, как прочитать свою ДНК дома. Автор разбирает бюджетный протокол MinION, типичные ошибки и мотивы эксперимента. Дальше слово автору.
Это руководство для инициативных и смелых энтузиастов, которые хотят узнать... |
| Oct 24, 2025 | Augment.us Evolves from Sourcing Tool to Candidate Engagement Driver Across All Career Levels | From early pilots to scalable engagement partnerships with global employers, AU's evolution reflects a growing demand for data-driven candidate connection tools aimed at assisting employers to reach the highest quality and most committ... |
| Aug 27, 2025 | Biokraft Foods Reveals Winners of the Great Indian Cultivated Chicken Cook-Off | Recently, Indian biotech company Biokraft Foods hosted the Great Indian Cultivated Chicken Cook-Off, a competition for promising young chefs.
The finalists were selected through a competitive process, and recently participated in a Grand Fi... |
| Aug 4, 2025 | Biokraft Foods to Host “India’s First” Cultivated Chicken Cook-Off | Indian biotech startup Biokraft Foods is set to host what is claimed to be the country’s first cultivated chicken cook-off.
The event will take place on August 22 at DY Patil University, School of Hospitality and Tourism Studies, Navi Mumba... |
| Apr 25, 2025 | Немецкая компания Merck купит американскую фармкомпанию SpringWorks за $3,5 млрд | Merck сообщила, что компании ведут переговоры на основе цены около $47 за акцию, что, по расчетам Reuters, дает оценку примерно в $3,5 млрд. Эта сделка может предоставить ей доступ к недавно одобренному препарату для лечения редкого заболев... |
| Apr 24, 2025 | Germany's Merck nears deal for SpringWorks, source says | Germany's Merck nears deal for SpringWorks, source says
By ReutersApril 24, 20257:54 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The logo of Merck pharmaceutical company is seen on the ... |
| Mar 14, 2025 | The Future of Work: AI and Data Apps Transforming Business Landscapes | In the fast-paced world of business, technology is the wind beneath our wings. Companies are racing to harness the power of artificial intelligence (AI) and data applications. These tools are not just enhancements; they are game-changers. T... |
| Mar 13, 2025 | Sigma Unveils Data Apps to Unify Business Workflows Directly on the Cloud Data Platform | New capabilities allow companies to build and automate data-driven workflows, diminishing reliance on fragmented SaaS tools
SaaS overload has become a significant obstacle for businesses, leading to fragmented workflows, inefficient process... |
| Feb 11, 2025 | Merck's Bold Move: Aiming for Growth Through Acquisition | In the world of pharmaceuticals, the quest for growth often leads to strategic acquisitions. Recently, Merck KGaA, the German healthcare giant, has set its sights on Springworks Therapeutics, a U.S. biotech firm specializing in cancer and r... |
| Feb 10, 2025 | Exclusive: Germany's Merck in advanced talks to acquire US biotech firm Springworks | Exclusive: Germany's Merck in advanced talks to acquire US biotech firm Springworks
By Sabrina Valle and Patricia WeissFebruary 10, 20258:43 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
... |
| Jan 23, 2025 | Pictor Biotech Inc. (d.b.a. SOLARBIOTECH), GPC Bio, and Eleszto Genetika Announce Strategic Unification | NORTON, Va., LA ROCHELLE, France and BUDAPEST, Hungary, Jan. 23, 2025 /PRNewswire/ -- Today, SOLARBIOTECH, GPC Bio, and Eleszto Genetika proudly announced their acquisition and strategic unification under a single ownership.
This consolidat... |
| Nov 1, 2024 | Merck Announces Emerging Biotech Grant Program Winners | Award recipients to receive in-kind technologies and services to accelerate therapeutics to market
Merck experts to provide consultation and training in qualification, risk assessment, and process optimization
Program extended this year to ... |
| Jul 22, 2024 | Charlie Forcey Joins Sustainability Roundtable, Inc. as CTO to Help Organize Off-Site Clean Energy Buyers Worldwide | BOSTON, July 22, 2024 /PRNewswire/ -- Sustainability Roundtable, Inc. (SR Inc), which works to be the world's most respected strategic advisor in enterprise decarbonization, announced today the appointment of Charlie Forcey to its C-Su... |
| Apr 9, 2024 | Merck India appoints Dhananjay Singh as MD of its Life Science unit | Merck, a leading science and technology company, on Tuesday announced the appointment of Dhananjay Singh as the managing director of Merck Life Science in India.
Effective April 1, 2024, Singh has taken over from Sreenath N S, who is retiri... |
| Mar 11, 2024 | L-Ergothioneine (EGT) Market Size, Share, Trends, Growth And Regulatory Landscape By 2024-2031 | AnaSpec, Inc. | L-Ergothioneine (EGT) Market
Global L-ergothioneine (EGT) market is projected to grow from US$ 40.8 Mn in 2023 to US$ 389.3 Mn by 2030, at a compound annual growth rate (CAGR) of 38%. BURLINGAME, CALIFORNIA, UNITED STATES, March 11, 2024 /E... |
| Dec 7, 2023 | Nine medical innovations with disruptive potential: Start-ups presented their ideas at the “Munich Demo Day” of the BioTech Bootcamp of BioM and SmiLe | As part of this year's BioTech Bootcamp of BioM Biotech Cluster Development GmbH and the life science business incubator „SmiLe Incubator“ from Lund, Sweden, the international, eight-week training program for prospective founders and y... |
| Nov 29, 2023 | Cradle raises $24m for GenAI biotech platform | |
| Sep 26, 2023 | Health | This lab’s gene test can find more rare diseases. This is what it can do for the ‘diagnostic odyssey’ of families. | There are more than 7,000 rare disorders, and many cannot be diagnosed in a doctor’s office.
That’s why genetic sequencing is so important.
Now The Jackson Laboratory in Farmington is able to sequence the entire genome, an advance that will... |
| Apr 26, 2023 | Sigma-Aldrich Selects VWO to Optimize Customer Experience | VWO becomes the choice of Sigma-Aldrich in the US for driving experience optimization
We wanted a partner to help us optimize our customer's experience. VWO has allowed us to save time in the agile process by testing new features prior... |
| Aug 11, 2022 | Demand-constrained Covid vaccine market may push South Africa's Aspen to change its direction | Last year, South African manufacturer Aspen Pharmacare was in a good position, as the company opened new manufacturing lines and started to pump out J&J’s single-dose Covid-19 vaccine — even hitching its wagon to mak... |
| Aug 11, 2022 | Advent to sell stake in manufacturer and drug developer in a deal worth over $1B — report | After almost three years of investment, private equity firm Advent International may look to sell its part in Bioduro-Sundia.
A Reuters report on Monday detailed that Advent International plans to sell a majority st... |
| Aug 11, 2022 | More than half a billion Covid vaccine doses wasted after Emergent's Baltimore fiasco | New congressional committee findings released Thursday show that 135 million more coronavirus vaccine doses manufactured at Emergent BioSolutions’ Baltimore-based facility for Johnson & Johnson were designat... |
| Aug 11, 2022 | Manufacturing roundup: MilliporeSigma launches new AAV platform; New IV fluid manufacturing facility is coming to central Florida | Merck KGaA’s MilliporeSigma has launched a new AAV production platform.
The platform will enable the CDMO to provide viral vector manufacturing including AAV, lentiviral, CDMO, CTO and process development faster whi... |
| Jul 8, 2021 | Partnering the new xMAP® INTELLIFLEX Platform with Partner Software: 5 Packages to Improve Your Data Analysis | Partnering the new xMAP® INTELLIFLEX Platform with Partner Software: 5 Packages to Improve Your Data Analysis
Posted on July 7, 2021 (Updated June 21, 2021) byHeather Darby
The launch of the new xMAP® INTELLIFLEX platform marks a reinvigora... |
| Sep 15, 2020 | Merck Expands BioReliance® Viral Clearance Offering in Singapore, Saving Customers Time | Allows customers to continue
developing lifesaving medicines amid Covid-19 pandemic
Customers can view the lab studies
“live” with Merck scientists
SINGAPORE
– Media OutReach – 15 September 2020 – Merck, a leading science and
technology com... |
| Apr 1, 2020 | Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic | Alain Mérieux, founder of BioMérieux.AFP via Getty Images |
| Aug 11, 2015 | CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here are 6 more biotechs shaping CRISPR landscape | But that’s already turned quickly on its head.
Confidence is growing in the technology, as evidenced by the title of a fantastic Wired article: “Easy DNA Editing Will Remake the World. Buckle Up.” And the broader scientific community is now... |
| May 13, 2015 | The Genome Engineering Revolution | Ryan Clarke Contributor
More posts by this contributor
A Third Act For Biofuels
James Hyun Contributor
More posts by this contributor
A Third Act For Biofuels
Editor’s note: Ryan Clarke is a biochemistry PhD candidate with an interest in ge... |
| Jul 23, 2014 | Beverage Entrepreneurs Forum: This is the only business where you send a customer an invoice, and you end up owing them money! | Speaking at the event - broadcast live on Wednesday and now available on demand (click HERE to register) - Odwalla founder Greg Steltenpohl - now CEO of California-based Califia Farms - said: “I shouldn’t really be here because Odwalla st... |
| Jun 15, 2014 | Sprayable Energy makes caffeine sprayable—but we couldn’t find the energy | One tube, $15, probably 500mg of caffeine (estimated).
Lee Hutchinson reader comments 122 with 77 posters participating, including story author
Share this story
Share on Facebook
Share on Twitter
Share on Reddit
The folks at Sprayable Energ... |
| Dec 9, 2013 | New dissolving patch delivers clotting factor directly to injury to stop bleeding faster | The FASTCLOT technology was developed by a research team at Virginia Commonwealth University and is exclusively licensed by St Teresa Medical. The company is developing products for both surgery (SURGICLOT®) and trauma (WRAPCLOT®), for civi... |
| Nov 24, 2011 | Genomic and proteomic research company orders robot | Genomic and proteomic research company orders robot
24-11-2011
Sigma-Aldrich, which does development in genomic and proteomic research, biotechnology and pharmaceuticals, has ordered a robot from ST Robotics.
Sigma-Aldrich a leading Life Sc... |
| Jun 30, 2008 | SAFC expands Halal raw materials for flavours | The company, which is a division of fine chemical firm Sigma Aldrich, launched its initial 350-strong Halal raw material offering last October. Dihn Phan, market segment manager, told FoodNavigator.com at the IFT trade show in New Orleans, ... |
| New dissolving patch delivers clotting factor directly to injury to stop bleeding faster | Hemorrhage is a primary cause of mortality in trauma patients even though most injuries suffered are potentially survivable. Increasing survival is simply a matter of effectively controlling hemorrhage. Current hemostatic dressings range fr... |
| Realizing the potential of CRISPR | For the past five years, Emory University’s Dr. Chris Raymond has been using genomic technology designed by MilliporeSigma especially for his lab to find, remove, and replace genes in mice. This popular method of editing genes, called CRISP... |
| CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here are 6 more biotechs shaping CRISPR landscape | CRISPR/Cas9 gene editing has zoomed to the forefront of the biotech investment scape in the past year — punctuated this week by Editas Medicine‘s impressive $120 million fundraise. Looks like it’s no longer hype — there’s solid funding to p... |